NINDS Cooperative Program in Translational Research Single Component Research Projects (U01) | Apply Online

Opportunity Summary:

The NINDS Cooperative Program in Translational Research Single Component Research Projects (U01) (PAR-11-153) is an NIH grant opportunity designed to move promising therapy concepts for neurological disorders through the late preclinical stage and toward readiness for first-in-human evaluation. The emphasis is on translational work that directly advances a specific therapeutic candidate, taking it from an already-validated lead (with demonstrated activity against the intended disease target) through the kinds of optimization, efficacy, and safety-enabling studies that are typically required before approaching the FDA. The underlying aim is to shorten the path between basic research discoveries and clinical testing by funding projects that are already past the discovery phase and are positioned to become real development programs.

A defining feature of this FOA is its requirement that projects be far enough along that an IND (Investigational New Drug) or IDE (Investigational Device Exemption) application could be submitted to the FDA by the end of the award period. In practice, that means applicants are expected to propose a clear, development-focused plan that addresses the key preclinical steps needed to support regulatory filing. This may include activities such as lead optimization, confirmation of pharmacologic activity, dose and regimen refinement, formulation work where relevant, characterization of pharmacokinetics and pharmacodynamics, development of translational assays, and other preclinical testing needed to justify moving into human studies. The program is described as therapy-directed, meaning the success metric is not new biological insight for its own sake, but a credible package of data that de-risks a specific therapeutic candidate and supports a regulatory submission.

Just as important are the boundaries of what the program will not fund. The FOA explicitly excludes early-stage therapeutic discovery work, including approaches like high-throughput screening meant to identify initial hits. It also excludes clinical research, as well as basic research or studies aimed primarily at understanding disease mechanisms. In other words, this program is not intended for exploratory biology, target discovery, or hypothesis-generating studies. It is meant for teams that already have a therapeutic lead in hand and need focused resources to complete the preclinical development work required to reach an IND/IDE milestone.

The award mechanism is a U01 cooperative agreement, which signals that this is not a standard investigator-initiated grant where the funding agency is mostly hands-off. Instead, it is a milestone-driven program with active involvement from NINDS staff. NINDS participates in developing the project plan and closely monitors progress against defined milestones, which typically means applicants should be prepared to propose objective go/no-go decision points, deliverables, timelines, and clear criteria for success. This structure is meant to keep projects on a development track, identify problems early, and ensure that funded work stays aligned with the goal of producing a clinical-ready therapeutic candidate.

Administratively, the opportunity sits within NIH under the National Institute of Neurological Disorders and Stroke (NINDS) and falls under the Health activity category, CFDA 93.853 (Extramural Research Programs in the Neurosciences and Neurological Disorders). The posted and creation date for this FOA was March 15, 2011, with an original and current closing date of September 7, 2011, and an archive date of October 8, 2011. The program does not require cost sharing or matching.

Eligibility is broad and includes many types of domestic applicants such as state, county, city/township, special district governments, public and private institutions of higher education, and independent school districts, as well as nonprofits (including those with and without 501(c)(3) status), small businesses, and other for-profit organizations (other than small businesses). It also extends to tribal governments and tribal organizations, public housing authorities/Indian housing authorities, and a range of designated institution types such as HBCUs, Hispanic-serving institutions, Alaska Native and Native Hawaiian Serving Institutions, and Tribally Controlled Colleges and Universities. The FOA also allows non-U.S. entities (foreign organizations), regional organizations, U.S. territories or possessions, and foreign components of U.S. organizations, reflecting an openness to international participation where appropriate.

For applicants, the practical takeaway is that competitiveness depends on presenting a development-ready therapeutic lead, strong preliminary evidence of activity, a realistic and regulator-oriented preclinical plan, and a milestone structure that demonstrates disciplined project management. The program is intended for translational teams ready to do the hard, methodical work that turns a promising lead into an IND/IDE-quality package, rather than teams still searching for targets, mechanisms, or initial hits.

Source link: http://grants.nih.gov/grants/guide/pa-files/PAR-11-153.html

Browse more opportunities from the same agency: National Institutes of Health

Browse more opportunities from the same category: Health

Next opportunity: ROSES 2011 Advancing Collaborative Connections for Earth System Science

Previous opportunity: Project Leading to Design and Development of Sustainable, Scalable Farmer or Community Seed Storage Models for Vulnerable Populations

USGrants.org Applicant Portal:

Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.

Apply for PAR 11 153

 

[Watch] how do funding administrators access proposals?

Applicants also applied for:

Applicants who have applied for this opportunity (PAR 11 153) also looked into and applied for these:

 

Grant application guides and resources

It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!

Apply for Grants

 

 

Premium leads for funding administrators, grant writers, and loan issuers

Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.

If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.

Subscribe to Leads

 

Request more information:

Would you like to learn more about this funding opportunity, similar opportunities to "PAR 11 153", eligibility, application service, and/or application tips? Submit an inquiry below:

Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.